Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0500
-0.0010 (-1.96%)
Apr 20, 2026, 3:54 PM AEST
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 52.58 million as of April 20, 2026. Its market cap has increased by 38.91% in one year.
Market Cap
52.58M
Enterprise Value
43.08M
Revenue
4.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 52.58M, an increase of 818.43%. That is a compound annual growth rate of 8.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 52.58M | -40.48% |
| Dec 31, 2025 | 88.33M | 119.36% |
| Dec 31, 2024 | 40.27M | -19.35% |
| Dec 29, 2023 | 49.93M | -48.68% |
| Dec 30, 2022 | 97.29M | -34.93% |
| Dec 31, 2021 | 149.52M | 248.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cynata Therapeutics | 85.48M |
| Amplia Therapeutics | 84.66M |
| LTR Pharma | 72.71M |
| Radiopharm Theranostics | 72.66M |
| Neurizon Therapeutics | 60.61M |
| Imugene | 53.55M |
| Proteomics International Laboratories | 45.43M |
| Entropy Neurodynamics | 45.28M |